Literature DB >> 20126984

Secreted form of EphA7 in lung cancer.

Masaru Tsuboi1, Hiroki Mori, Tomoyasu Bunai, Shinji Kageyama, Masaya Suzuki, Koji Okudela, Kazuya Takamochi, Hiroshi Ogawa, Hiroshi Niwa, Kazuya Shinmura, Haruhiko Sugimura.   

Abstract

EPHA7 is a member of the EPHA family of receptor kinases, among which several members are known to be involved in human lung carcinogenesis. We report here a novel spliced variant, the so-called secreted form of EPHA7, recently reported in malignant lymphoma, in human lung cancer cell lines and primary lung cancer. In contrast to the EPHA7 down-regulation in colorectal cancer by promoter hypermethylation, EPHA7 is expressed at a substantial level in most human lung cancers and the secreted form of EPHA7 mRNA was found in a fraction of primary lung cancer tissues, lung cancer cell lines, and immortalized bronchogenic epithelial cell lines. Interestingly, the secreted form of EPHA7 message was predominantly detected in non-adeno type lung carcinoma. The mechanistic role of the secreted form of EPHA7 in human lung carcinogenesis is not clear, but the presence of this form could distinctly exclude adenocarcinoma of the lung from the other categories, i.e., squamous cell carcinoma, small cell carcinoma and large cell carcinoma, which have strong association with smoking. This is the first study to detect the secreted form of EPHA7 in human epithelial tissues. EPHA7 warrants further investigation to determine its possible involvement in smoking related lung carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20126984

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  11 in total

1.  PLK4 overexpression and its effect on centrosome regulation and chromosome stability in human gastric cancer.

Authors:  Kazuya Shinmura; Nobuya Kurabe; Masanori Goto; Hidetaka Yamada; Hiroko Natsume; Hiroyuki Konno; Haruhiko Sugimura
Journal:  Mol Biol Rep       Date:  2014-07-01       Impact factor: 2.316

2.  EPH-EPHRIN in human gastrointestinal cancers.

Authors:  Haruhiko Sugimura; Jian-Dong Wang; Hiroki Mori; Masaru Tsuboi; Kiyoko Nagura; Hisaki Igarashi; Hong Tao; Ritsuko Nakamura; Hiroko Natsume; Tomoaki Kahyo; Kazuya Shinmura; Hiroyuki Konno; Yasushi Hamaya; Shigeru Kanaoka; Hideki Kataoka; Xiao-Jun Zhou
Journal:  World J Gastrointest Oncol       Date:  2010-12-15

3.  EPHA7 and EPHA10 Physically Interact and Differentially Co-localize in Normal Breast and Breast Carcinoma Cell Lines, and the Co-localization Pattern Is Altered in EPHB6-expressing MDA-MB-231 Cells.

Authors:  Candace Johnson; Briana Segovia; Raj P Kandpal
Journal:  Cancer Genomics Proteomics       Date:  2016 09-10       Impact factor: 4.069

4.  A Bayesian ensemble approach with a disease gene network predicts damaging effects of missense variants of human cancers.

Authors:  Hong-Hee Won; Jong-Won Kim; Doheon Lee
Journal:  Hum Genet       Date:  2012-08-21       Impact factor: 4.132

5.  Identification of the soluble EphA7-interacting protein Nicalin as a regulator of EphA7 expression.

Authors:  Xiaolei Wang; Zhaobao Wang
Journal:  Mol Cell Biochem       Date:  2020-09-10       Impact factor: 3.396

6.  Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers.

Authors:  Xifeng Wu; Liang Wang; Yuanqing Ye; Jeremiah A Aakre; Xia Pu; Gee-Chen Chang; Pan-Chyr Yang; Jack A Roth; Randolph S Marks; Scott M Lippman; Joe Y Chang; Charles Lu; Claude Deschamps; Wu-Chou Su; Wen-Chang Wang; Ming-Shyan Huang; David W Chang; Yan Li; V Shane Pankratz; John D Minna; Waun Ki Hong; Michelle A T Hildebrandt; Chao Agnes Hsiung; Ping Yang
Journal:  Cancer Res       Date:  2013-05-23       Impact factor: 12.701

Review 7.  The role of EphA7 in different tumors.

Authors:  Xiangyi Chen; Dechen Yu; Haiyu Zhou; Xiaobo Zhang; Yicun Hu; Ruihao Zhang; Xidan Gao; Maoqiang Lin; Taowen Guo; Kun Zhang
Journal:  Clin Transl Oncol       Date:  2022-02-02       Impact factor: 3.405

8.  Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines.

Authors:  Radosław Januchowski; Karolina Sterzyńska; Piotr Zawierucha; Marcin Ruciński; Monika Świerczewska; Małgorzata Partyka; Katarzyna Bednarek-Rajewska; Maciej Brązert; Michał Nowicki; Maciej Zabel; Andrzej Klejewski
Journal:  Oncotarget       Date:  2017-07-25

9.  MicroRNA-448 suppresses osteosarcoma cell proliferation and invasion through targeting EPHA7.

Authors:  Xiangkun Wu; Lihua Yan; Yongxi Liu; Wenfeng Xian; Liuyu Wang; Xunmeng Ding
Journal:  PLoS One       Date:  2017-06-12       Impact factor: 3.240

10.  Ephrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival.

Authors:  Constantinos Giaginis; Nikolaos Tsoukalas; Evangelos Bournakis; Paraskevi Alexandrou; Nikolaos Kavantzas; Efstratios Patsouris; Stamatios Theocharis
Journal:  BMC Clin Pathol       Date:  2014-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.